Welcome to LookChem.com Sign In|Join Free
  • or
N'-(isobutyryl)benzohydrazide is an organic compound with the chemical formula C11H14N2O2. It is a derivative of benzohydrazide, where the hydrogen atom of the hydrazide group is replaced by an isobutyryl group. N'-(isobutyryl)benzohydrazide is white to off-white in color and is soluble in organic solvents. It is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly in the production of certain anti-inflammatory and analgesic drugs. The compound is also known for its potential applications in the development of new materials and as a research tool in chemical and pharmaceutical studies.

6913-90-2

Post Buying Request

6913-90-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6913-90-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 6913-90-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,1 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6913-90:
(6*6)+(5*9)+(4*1)+(3*3)+(2*9)+(1*0)=112
112 % 10 = 2
So 6913-90-2 is a valid CAS Registry Number.

6913-90-2Relevant academic research and scientific papers

Light-emitting compound

-

Paragraph 0216; 0217; 0218, (2018/03/24)

A phosphorescent compound of formula (I): wherein M is a transition metal; L is a ligand; R1 is a branched C3-20 alkyl group, a cyclic C5-20 alkyl group or group of formula (II): wherein each R5 is aC1-10 alkyl group; each R6 is a substituent; z is 0 or a positive integer; R2 is a C1-10 alkyl group; R3 is a C1-10 alkyl group or a group of formula -(Ar1)p wherein Ar1 is aryl or heteroaryl group and p is at least 1; each R4 is independently a substituent; v is at least 1; w is 0 or a positive integer; x is at least 1; and y is 0 or a positive integer. The compound may be used as a blue light-emitting material in an organic light-emitting device.

Tunable protic ionic liquids as solvent-catalysts for improved synthesis of multiply substituted 1,2,4-triazoles from oxadiazoles and organoamines

Chen, Xiaofeng,Liu, Rui,Xu, Yuan,Zou, Gang

experimental part, p. 4813 - 4819 (2012/07/31)

More than green alternatives to traditional volatile molecular organic solvents, protic ionic liquids as dual solvent-catalysts have been successfully used to promote reactions of organoamines with oxadiazoles to afford sterically hindered 1,2,4-triazoles. Among the tested protic ionic liquids, pyridinium trifluoroacetate and acetate showed the highest efficiency for the reactions of arylamines and alkylamines, respectively, indicating that tunable catalysis could be readily effected with protic ionic liquid solvent-catalysts by simply tuning their cation and anion counterparts. A general and efficient approach has been developed for synthesis of multiply substituted 1,2,4-triazoles based on the tunable protic ionic liquid solvent-catalyst systems.

Reaction of 3-formylchromone-N-benzoylhydrazone with ketenes. Synthesis and structural studies of chromone 1,3,4-oxadiazolines

Kaspentakis, George C.,Tsoleridis, Constantinos A.,Stephanidou-Stephanatou, Julia

, p. 425 - 430 (2008/03/29)

(Chemical Equation Presented) The reaction of 3-formylchromone-N- benzoylhydrazone with ketenes, prepared in situ from the corresponding acid chlorides 2a-d and the mixed anhydride 2e was studied. In all cases 2-(4′-oxo-4′H-3′-chromyl)-5-phenyl-2,3-dihydro-1,3, 4-oxadiazoles (3) were isolated in yields varying from 40 to 80%. A full structure assignment of all products has been made on the basis of 1D and 2-D (COSY H-H, COSY C-H, COLOC C-H) NMR spectra. A plausible reaction mechanism is also proposed based on theoretical approaches and experimental results.

4-Oxa and 4-thia steroids

-

, (2008/06/13)

The compounds of the present invention are those of structural formula (I) STR1 wherein X is oxygen or sulfur. Pharmaceutical compositions and methods of use of the compounds in the treatment of hyperandrogenic conditions are disclosed. In addition, the combination of the compounds with other active agents such as finasteride, minoxidil and retinoic acid or a derivative thereof is disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6913-90-2